<p>People who currently smoke, and those with chronic obstructive pulmonary disease (COPD) may have higher levels of a molecule in their lungs, which could put them at an increased risk of developing severe COVID-19 infections, according to a study.</p>.<p>The study, published in the European Respiratory Journal, shows that levels of angiotensin converting enzyme II (ACE-2) --which sits on the surface of lung cells -- in former smokers is lower than in current smokers.</p>.<p><a href="https://www.deccanherald.com/national/coronavirus-news-live-updates-karnataka-sees-12-more-covid-19-cases-indias-tally-reaches-4348-817763.html"><strong>For latest updates on coronavirus outbreak, click here</strong></a></p>.<p>"The data emerging from China suggested that patients with COPD were at higher risk of having worse outcomes from COVID-19," said Janice Leung from the University of British Columbia in Canada.</p>.<p>"We hypothesised that this could be because the levels of ACE-2 in their airways might be increased compared to people without COPD, which could possibly make it easier for the virus to infect the airway," Leung said.</p>.<p>The researchers studied samples taken from the lungs of 21 COPD patients and 21 people who did not have COPD.</p>.<p>They tested the samples to gauge the level of ACE-2 and compared this with other factors, such whether they were from people who never smoked, were current smokers or former smokers.</p>.<p>Not only did they find higher levels of ACE-2 in COPD patients, they also found higher levels in people who were smokers.</p>.<p>The researchers then checked their new findings against two existing study groups, which together contain data on a further 249 people -- some non-smokers, some current smokers and some former smokers.</p>.<p>They found levels of ACE-2 were higher in current smokers but lower in non-smokers and in those who were former smokers.</p>.<p><a href="https://www.deccanherald.com/national/coronavirus-india-update-state-wise-total-number-of-confirmed-cases-deaths-on-april-13-824675.html"><strong>Coronavirus India update: State-wise total number of confirmed cases, deaths on April 13</strong></a></p>.<p>"We found that patients with COPD and people who are still smoking have higher levels of ACE-2 in their airways, which might put them at an increased risk of developing severe COVID-19 infections.</p>.<p>"Patients with COPD should be counselled to strictly abide by social distancing and proper hand hygiene to prevent infection," said Leung.</p>.<p>"We also found that former smokers had similar levels of ACE-2 to people who had never smoked. This suggests that there has never been a better time to quit smoking to protect yourself from COVID-19," she said.</p>.<p>Professor Tobias Welte, an infections expert from the European Respiratory Society said the study gives interesting insight into why some people may be at risk of more severe COVID-19 symptoms than others.</p>.<p>"What it does not tell us is whether it's possible to manipulate ACE-2 levels to improve survival in patients infected with COVID-19 or whether this would make a difference in COPD patients who contract the infection," said Welte, who was not involved in the study.</p>
<p>People who currently smoke, and those with chronic obstructive pulmonary disease (COPD) may have higher levels of a molecule in their lungs, which could put them at an increased risk of developing severe COVID-19 infections, according to a study.</p>.<p>The study, published in the European Respiratory Journal, shows that levels of angiotensin converting enzyme II (ACE-2) --which sits on the surface of lung cells -- in former smokers is lower than in current smokers.</p>.<p><a href="https://www.deccanherald.com/national/coronavirus-news-live-updates-karnataka-sees-12-more-covid-19-cases-indias-tally-reaches-4348-817763.html"><strong>For latest updates on coronavirus outbreak, click here</strong></a></p>.<p>"The data emerging from China suggested that patients with COPD were at higher risk of having worse outcomes from COVID-19," said Janice Leung from the University of British Columbia in Canada.</p>.<p>"We hypothesised that this could be because the levels of ACE-2 in their airways might be increased compared to people without COPD, which could possibly make it easier for the virus to infect the airway," Leung said.</p>.<p>The researchers studied samples taken from the lungs of 21 COPD patients and 21 people who did not have COPD.</p>.<p>They tested the samples to gauge the level of ACE-2 and compared this with other factors, such whether they were from people who never smoked, were current smokers or former smokers.</p>.<p>Not only did they find higher levels of ACE-2 in COPD patients, they also found higher levels in people who were smokers.</p>.<p>The researchers then checked their new findings against two existing study groups, which together contain data on a further 249 people -- some non-smokers, some current smokers and some former smokers.</p>.<p>They found levels of ACE-2 were higher in current smokers but lower in non-smokers and in those who were former smokers.</p>.<p><a href="https://www.deccanherald.com/national/coronavirus-india-update-state-wise-total-number-of-confirmed-cases-deaths-on-april-13-824675.html"><strong>Coronavirus India update: State-wise total number of confirmed cases, deaths on April 13</strong></a></p>.<p>"We found that patients with COPD and people who are still smoking have higher levels of ACE-2 in their airways, which might put them at an increased risk of developing severe COVID-19 infections.</p>.<p>"Patients with COPD should be counselled to strictly abide by social distancing and proper hand hygiene to prevent infection," said Leung.</p>.<p>"We also found that former smokers had similar levels of ACE-2 to people who had never smoked. This suggests that there has never been a better time to quit smoking to protect yourself from COVID-19," she said.</p>.<p>Professor Tobias Welte, an infections expert from the European Respiratory Society said the study gives interesting insight into why some people may be at risk of more severe COVID-19 symptoms than others.</p>.<p>"What it does not tell us is whether it's possible to manipulate ACE-2 levels to improve survival in patients infected with COVID-19 or whether this would make a difference in COPD patients who contract the infection," said Welte, who was not involved in the study.</p>